TCTMD
VerifiedOnline/Digital
TMD is the most comprehensive on-line resource in interventional cardiology and provides indepth coverage of the percutaneous treatment of cardiovascular disease. Since its launch at TCT 2000, TCTMD has provided clinicians and industry professionals myriad ways to keep up-to-date in the ever-evolving field, including news and data from conferences hosted around the world as well as information about the latest devices and drugs used in the daily practice of cardiovascular medicine.
TCTMD is produced and administered by the Cardiovascular Research Foundation (CRF). CRF's mission is to strive to improve the quality of life for patients with cardiovascular disease. The organization's goal is to advance the development and use of safe and effective minimally invasive cardiovascular treatments. For more information, visit our Web site at http://www.crf.org. Source
Actions
Media Outlet details
| Scope | National, Trade/B2B |
|---|---|
| Language | English, Spanish |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesNow Published: POLY-HF Shows Polypill Pays Dividends in Patients With HFrEF
The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain. TCTMD reported on POLY-HF after its November 14, 2025, presentation at the AHA Scientific Sessions. The study has now been published in Nature Medicine.
Sublingual Nitroglycerin Appears Safe, Helpful for Pre-TAVI CCTA
News Conference News SCCT 2026 Long contraindicated in patients with severe AS, the vasodilator may improve image quality with careful monitoring. CHULA VISTA, CA—Giving sublingual nitroglycerin to patients with severe aortic stenosis (AS) in pre-TAVI coronary computed tomography angiography (CCTA) assessments appears safe and can improve image quality, new prospective data show.
What’s in a Name? Researchers Push for MINOCA Rethink
Changing the “I” from infarction to injury might better represent the nature of MINOCA as a working diagnosis. A closer look at the diversity of factors associated with myocardial infarction in the absence of obstructive coronary arteries (MINOCA) is raising the question of whether the acronym needs an overhaul to better align it with the uncertain realities of the condition.
Shikha Jha, MD
Shikha Jha, MD, is chief interventional cardiology fellow at Corewell Health William Beaumont University Hospital (Royal Oak, MI). Originally from Nepal, she studied medicine at the National Medical College in Birgunj and moved to the US for postgraduate medical education at Harvard Medical School (Boston, MA). Jha trained in internal medicine at Saint Peter’s University Hospital (New Brunswick, NJ) and completed her cardiovascular medicine fellowship at the University of Wisconsin-Madison.
NHANES Data Point to Subpar Treatment of Risk Factors in CKM Syndrome
It’s critical to focus on treatment intensification, and not just initiation, in high-risk patients, Ambarish Pandey says. When it comes to treating risk factors in patients with cardiovascular-kidney-metabolic (CKM) syndrome, there is much room for improvement, a look at data from the National Health and Nutrition Examination Survey (NHANES) indicates.
BMI Appears to Carry Less Weight as Medical Therapy Improves
In industrialized countries, the gaps in systolic BP and cholesterol have shrunk between obese and normal-weight individuals. Over the past three decades, gaps in key cardiovascular risk factors—specifically systolic blood pressure and non-HDL cholesterol levels—have shrunk between individuals with obesity versus normal body weight living in industrialized countries, according to a new study by the NCD Risk Factor Collaboration (NCD-RisC).
SCCT 2026: What to Expect in Chula Vista
News Conference News SCCT 2026 The meeting offers something for all: from the practicalities of running a cardiac CT program to the effect of AI on the field. The annual conference of the Society of Cardiovascular Computed Tomography (SCCT) is set to kick off this week in Chula Vista, CA, right next door to San Diego, running from July 9 to 12.
Interventional Cardiology Fellow on Call: Starting a New Adventure
News Opinion Fellow Talk With her first weekend call—including middle-of-the-night STEMI activation—behind her, Shikha Jha reflects on lessons learned. As someone who has always been more about the journey than the destination, I was simultaneously motivated and enthusiastic earlier this month to embrace the adventure of moving from Wisconsin to Michigan to start my interventional cardiology fellowship.
SCCT 2026
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives. For more information, visit http://www.crf.org.
AI-ECG Models Detect Structural Heart Disease, Identify At-Risk Patients
News Conference News NY Valves 2026 The tools may help address underdiagnosis in this area, though there is still room for improvement in screening performance. NEW YORK, NY—Artificial intelligence-enabled ECG (AI-ECG) tools reflective of systolic and diastolic dysfunction are able to identify patients with structural heart disease (SHD) who would benefit from definitive evaluation with echocardiography, new data suggest.